Emma Ahlqvist, Subclassification of type 2 diabetes – New genes and new mechanisms, 500 000
Sebastian Albinsson, Reprogramming of smooth muscle cells can cause vascular disease – identification of underlying mechanisms and possible treatment methods, 300 000
Klinsmann Carolo Dos Santos, A membrane-centric view on dietary lipids and adipocyte function, 100 000
Andreas Edsfeldt, Apoptosis and efferocytosis as underlying causes of impaired tissue repair in diabetes-associated cardiovascular complications, 300 000
Sofia Enhörning, WATer and Environment Related to CArdiovascular, Metabolic and Preeclamptic States (WATERCAMPS), 300 000
Viktor Hamrefors, Cardiovascular autonomic dysfunction – an underestimated and modifiable risk factor for cardiovascular disease and COPD?, 300 000
Ola Hansson, Development of an exercise mimetic to treat thromboembolism, 200 000
Sebastian Kalamajski, Investigation of genetic variants in MTIF3, relevant for personalised obesity treatment, 200 000
Ben King, Roles of C3 in diabetes, 1 200 000
Marlena Maziarz, National research initiative for a large-scale analysis of symptoms, exposure and risk factors associated with covid-19 infection: COVID Symptom Study in Sweden, 400 000
Luis Sarmiento-Pérez, Dysregulation of pancreatic beta-cell autophagy – A viral strategy to promote beta-cell dysfunction and type 1 diabetes?, 200 000
Alexandru Schiopu, Development of a novel immunomodulatory therapy against cardiac inflammation, 300 000
Emily Sonestedt, Are dietary habits with low climate impact associated with reduced cardiometabolic disease risk?, 300 000
Karin Stenkula, Mechanosensing and EHD2: key factors regulating adipocyte function, 300 000
Enming Zhang, Reversal of insufficient insulin secretion in diabetic beta cells by controlling mechanical force stimulated insulin secretion, 400 000